Home9VC • ETR
add
ATAI Life Sciences NV
Previous close
€0.95
Day range
€0.96 - €0.99
Year range
€0.96 - €2.47
Market cap
181.22M USD
Avg Volume
702.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 273.00K | 58.72% |
Operating expense | 26.00M | -18.83% |
Net income | -57.31M | -73.45% |
Net profit margin | -20.99K | -9.28% |
Earnings per share | -0.36 | -71.43% |
EBITDA | -25.65M | 19.31% |
Effective tax rate | -0.03% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 88.35M | -61.17% |
Total assets | 215.78M | -14.91% |
Total liabilities | 47.24M | 24.47% |
Total equity | 168.53M | — |
Shares outstanding | 167.80M | — |
Price to book | 0.95 | — |
Return on assets | -26.53% | — |
Return on capital | -29.45% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -57.31M | -73.45% |
Cash from operations | -16.23M | 28.24% |
Cash from investing | 16.30M | 174.08% |
Cash from financing | 326.00K | 426.00% |
Net change in cash | 465.00K | 101.04% |
Free cash flow | -25.73M | -138.65% |
About
Founded
2018
Website
Employees
83
